8
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Immunohistochemical evaluation of p53 and Retinoblastoma proteins in relation to hyperthermia treatment: Results in human urothelial carcinomas

, , , &
Pages 813-824 | Received 12 May 1995, Accepted 27 May 1996, Published online: 09 Jul 2009

References

  • Andrews G. K., Harding M. A., Calvet J. P., Adamson E. D. The heat shock response in HeLa cells is accompanied by elevate expression of the c-fos proto-oncogene. Molecular and Cellular Biology 1987; 7: 3452–3458
  • Armitage P. Statistical methods in medical research. Blackwell Scientific, OxfordEngland 1973; 135
  • Cairns P., Proctor A. J., Knowles M. A. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 1991; 6: 2305–2309
  • Cordon-Cardo C., Finstad C. L., Bander N. H., Melamed M. R. Immuno anatomic distribution of cytostructural and tissue-associated antigens in the human urinary tract. American Journal of Pathology 1987; 126: 269–284
  • Cordon-Cardo C., Wartinger D., Petrylak D., Dalbagni G., Fair W. R., Funs Z., Reuter V. E. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. Journal of the National Cancer Institute 1992; 84: 1251–1256
  • Dalbagni G., Presti J., Reuter V., Fair W. R., Cordon-Cardo C. Genetic alterations in bladder cancer. Lancet 1993; 342: 469–471
  • Engelhardt R., Müller V., Weth-Simon R. Treatment of disseminated malignant melanoma with cisplatin in combination with whole body hyperthermia and doxorubicin. International Journal of Hyperthermia 1990; 6: 511–515
  • Fan S., El-Deiry W. S., Bae I., Freeman J., Jondle D., Bhatia K., Fornace A. J., Jr., Magrath I., Kohn K. W., O'Connor P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Research 1994; 54: 5824–5830
  • Fujimoto K., Yamada Y., Okajima E., Kakizoe T., Sasaki H., Sugimura T., Terada M. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Research 1992; 52: 1393–1398
  • Habuchi T., Takahashi R., Yamada H., Ogawa O., Kakehi Y., Ogura K., Hamazaki S., Toguchida J., Ishizaki K., Fujita J., Sugiyama T., Yoshida O. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Research 1993; 53: 3795–3799
  • Hainaut P., Milner J. Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. The EMBO Journal 1992; 11: 3513–3520
  • Hollstein M., Sidransky D., Vogelstain B., Harris C. C. p53 mutations in human cancers. Science 1991; 253: 49–53
  • Ishikawa J., Xu H. J., Hu S. X., Yandell D. W., Maeda S., Kamidono S., Benedict W. F., Takahashi R. Inactivation of retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Research 1991; 51: 5736–5743
  • Kasid U., Pfeifer A., Weichselbaum R. R., Dritschilo A., Mark G. E. The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 1987; 237: 1039–1041
  • Kubota Y., Yao M., Ishibashi Y., Miura T., Shuin T., Hosada M., Takebayashi S., Watai K., Matsui K. The use of capacitive type shortwave radio-frequency hyper thermia in the treatment of urological cancers. Regional Cancer Treatment 1988; 1: 117–122
  • Levine A. J., Momand J., Finlay C. A. The p53 tumor suppressor gene. Nature 1991; 351: 453–456
  • Lowe S. W., Bodis S., McClatchey A., Remington L., Ruley H. E., Fisher D. E., Housman D. E., Jacks T. p53 status and the efficacy of cancer therapy in vivo Science 1994; 266: 807–810
  • Masunaga S., Hiraoka M., Takahashi M., Jo S., Akuta K., Nishimura Y., Nagata Y., Abe M. Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer-comparison of results with radiotherapy alone. International Journal of Hyperthermia 1990a; 6: 489–497
  • Masunaga S., Hiraoka M., Akuta K., Nishimura Y., Nagata Y., Jo S., Takahashi M., Abe M. Non-randomized trials of thermoradiotherapy versus radiotherapy for preoperative treatment of invasive urinary bladder cancer. The Journal of The Japanese Society for Therapeutic Radiology and Oncology 1990b; 2: 313–320
  • Mørkve O., Høstmark J. Influence of tissue preparation techniques on p53 expression in bronchial and bladder carcinomas, assessed by immunofluorescence staining and flow cytometry. Cytometry 1991; 12: 622–627
  • Nagata Y., Hiraoka M., Akuta K., Abe M., Takahashi M., Jo S., Nishimura Y., Masunaga S., Fukuda M., Imura H. Radiofrequency thermotherapy for malignant liver tumors. Cancer 1987; 65: 1730–1736
  • Nihei T., Takahashi S., Sagae S., Sato N., Kikuchi K. Protein interaction of retinoblastoma gene product pRbl 10 with MT 73,000 heat shock cognate protein. Cancer Research 1993; 53: 1702–1705
  • Overgaard J. The current and potential role of hyperthermia in radiotherapy. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 535–549
  • Perez C. A., Pajak T., Emami B., Hornback N. B., Tupchong L., Rubin P. Randomized phase 3 study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors: final report by the Radiation Therapy Oncology Group. American Journal of Clinical Oncology 1991; 14: 133–141
  • Presti J. C., Jr, Reuter V. E., Galan T., Fair W. R., Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Research 1991; 51: 5405–5409
  • Sidransky D., Von Eschenbach A., Tsai Y. C., Jones P., Summerhayes I., Marshall F., Paul M., Green P., Hamilton S. R., Frost P., Vogelstein B. Identifica tion of p53 gene mutations in bladder cancers and urine samples. Science 1991; 252: 706–709
  • Sneed P. K., Gutin P. R., Stauffer P. R., Phillips T. L., Prados M. D., Weaver K. A., Suen S., Lamb S. A., Ham B., Ahn D. K., Lamborn K., Larson D. A., Wara W. M. Thermoradiotherapy of recurrent malignant brain tumors. International Journal of Radiation Oncology, Biology and Physics 1992; 23: 853–863
  • Spruck I II C. H., Rideout I II W. M., Olumi A. F., Ohneseit P. F., Yang A. S., Tsai Y. C., Nichols P. W., Horn T., Harmann G. G., Steven K., Ross R. K., Yu M. C., Jones P. A. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage. Cancer Research 1993; 53: 1162–1166
  • Spruck I II C. H., Ohneseit P. F., Gonzalez-Zulueta M., Esrig D., Miyao N., Tsai Y. C., Lerner S. P., Schmutte C., Yang A. S., Cote R., DubeAu L., Nichols P. W., Harmann G. G., Steven K., Horn T., Skinner D. G., Jones P. A. Two molecular pathways to transitional cell carinoma of the bladder. Cancer Research 1994; 54: 784–788
  • Storm F. K. Clinical hyperthermia and chemotherapy. Radiologic Clinics of North America 1989; 27: 621–627
  • Suzuki K., Watanabe M., Miyoshi J. Differences in effects of oncogenes on resistance to γ rays, ultraviolet light, and heat shock. Radiation Research 1992; 129: 157–162
  • Taira T., Negishi Y., Kihara F., Iguchi-Ariga S. M. M., Ariga H. c-myc protein complex binds to two sites in hutnkan hsp70 promoter region. Biochemica et Biophysica Acta 1992; 1130: 166–174
  • UICC. TNM classification of malignant tumorsThird Edition. Geneva. 1978
  • Valdagni R., Amichetti M., Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized trial. International Journal of Radiation Oncology, Biology and Physics 1988; 15: 13–24
  • Xu H. J., Cairns P., Hu S. X., Knowles M. A., Benedict W. F. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. International Journal of Cancer 1993; 53: 781–784

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.